IL165505A0 - 2-heteroaryl carboxamides - Google Patents

2-heteroaryl carboxamides

Info

Publication number
IL165505A0
IL165505A0 IL16550504A IL16550504A IL165505A0 IL 165505 A0 IL165505 A0 IL 165505A0 IL 16550504 A IL16550504 A IL 16550504A IL 16550504 A IL16550504 A IL 16550504A IL 165505 A0 IL165505 A0 IL 165505A0
Authority
IL
Israel
Prior art keywords
heteroaryl carboxamides
carboxamides
heteroaryl
prophylaxis
learning
Prior art date
Application number
IL16550504A
Other languages
English (en)
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10257078A external-priority patent/DE10257078A1/de
Priority claimed from DE2002157537 external-priority patent/DE10257537A1/de
Priority claimed from DE10305922A external-priority patent/DE10305922A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of IL165505A0 publication Critical patent/IL165505A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL16550504A 2002-06-10 2004-12-02 2-heteroaryl carboxamides IL165505A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10225536 2002-06-10
DE10257078A DE10257078A1 (de) 2002-12-06 2002-12-06 2-Heteroarylcarbonsäureamide
DE2002157537 DE10257537A1 (de) 2002-12-10 2002-12-10 2-Heteroarylcarbonsäureamide
DE10305922A DE10305922A1 (de) 2002-06-10 2003-02-13 2-Heteroarylcarbonsäureamide
PCT/EP2003/005735 WO2003104227A1 (de) 2002-01-20 2003-06-02 2-heteroarylcarbonsäureamide

Publications (1)

Publication Number Publication Date
IL165505A0 true IL165505A0 (en) 2006-01-15

Family

ID=29740887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16550504A IL165505A0 (en) 2002-06-10 2004-12-02 2-heteroaryl carboxamides

Country Status (16)

Country Link
US (5) US7977485B2 (enExample)
EP (1) EP1515967B1 (enExample)
JP (1) JP4542891B2 (enExample)
CN (1) CN1675204A (enExample)
AT (1) ATE344262T1 (enExample)
AU (1) AU2003238450A1 (enExample)
BR (1) BR0312446A (enExample)
CA (1) CA2488761C (enExample)
DE (1) DE50305587D1 (enExample)
ES (1) ES2276072T3 (enExample)
IL (1) IL165505A0 (enExample)
MX (1) MXPA04012439A (enExample)
NO (1) NO20050063L (enExample)
PL (1) PL374551A1 (enExample)
UY (1) UY27841A1 (enExample)
WO (1) WO2003104227A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
ATE344262T1 (de) * 2002-06-10 2006-11-15 Bayer Healthcare Ag 2-heteroarylcarbonsäureamide
AU2003276919B2 (en) 2002-09-25 2013-05-16 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE602004031124D1 (de) 2003-08-13 2011-03-03 Neurosearch As Neue chinuklidinderivative und deren pharmazeutische verwendung
WO2005063767A2 (en) 2003-12-22 2005-07-14 Memory Pharmaceuticals Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
US20050234095A1 (en) 2004-03-25 2005-10-20 Wenge Xie Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
US7514450B2 (en) 2004-05-19 2009-04-07 Neurosearch A/S Azabicyclic aryl derivatives
CN100588657C (zh) 2004-10-15 2010-02-10 神经研究公司 新的氮杂双环芳基衍生物及其医药用途
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
CN101910159B (zh) 2007-12-26 2013-06-19 卫材R&D管理有限公司 杂环取代吡啶衍生物的制备方法
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
JP5749797B2 (ja) 2010-05-17 2015-07-15 フォルム ファーマシューティカルズ、インコーポレイテッド （ｒ）−７−クロロ−ｎ−（キヌクリジン−３−イル）ベンゾ［ｂ］チオフェン−２−カルボキサミド塩酸塩一水和物の結晶形
KR20130132932A (ko) 2010-12-20 2013-12-05 아스트라제네카 아베 2-카르복스아미드-4-피페라지닐-벤조푸란 유도체
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法
EP4213832A4 (en) * 2020-09-18 2024-10-16 Merck Sharp & Dohme LLC Modified benzofuran-carboxamides as glucosylceramide synthase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
EA007429B1 (ru) 2001-10-02 2006-10-27 Фармация Энд Апджон Компани Азабициклические замещённые конденсированные гетероарильные соединения
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
ATE344262T1 (de) * 2002-06-10 2006-11-15 Bayer Healthcare Ag 2-heteroarylcarbonsäureamide
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe

Also Published As

Publication number Publication date
US20060160877A1 (en) 2006-07-20
UY27841A1 (es) 2003-12-31
PL374551A1 (en) 2005-10-31
NO20050063L (no) 2005-01-06
US20120258964A1 (en) 2012-10-11
US7977485B2 (en) 2011-07-12
US10214524B2 (en) 2019-02-26
CA2488761C (en) 2011-05-31
WO2003104227A1 (de) 2003-12-18
EP1515967B1 (de) 2006-11-02
AU2003238450A1 (en) 2003-12-22
US20160122337A1 (en) 2016-05-05
BR0312446A (pt) 2005-04-19
CN1675204A (zh) 2005-09-28
JP4542891B2 (ja) 2010-09-15
US20140350008A1 (en) 2014-11-27
MXPA04012439A (es) 2005-04-19
JP2005533052A (ja) 2005-11-04
DE50305587D1 (en) 2006-12-14
EP1515967A1 (de) 2005-03-23
US9067931B2 (en) 2015-06-30
ATE344262T1 (de) 2006-11-15
ES2276072T3 (es) 2007-06-16
CA2488761A1 (en) 2003-12-18
US20110263591A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
NL300933I2 (nl) Letermovir
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
ATE408601T1 (de) Fredericamycin-derivate
WO2005063734A3 (de) Substituierte thiophene
ATE453642T1 (de) Substituierte phenylaminopyrimidine
MA28613B1 (fr) Macrocycles d'amide antibacteriens
WO2003078430A8 (de) Essig- und propionsäureamide
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
TW200510449A (en) Acylated nonadepsipeptides
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
TW200621799A (en) Acylated nonadepsipeptides II
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
ATE455789T1 (de) Substituierte nonadepsipeptide
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
TW200508237A (en) 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
PL367401A1 (en) Utilization of buprenorphine in urinary incontinence therapy
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
WO2003064394A8 (de) 5-ring heterozyklen zur verwendung als antiviral mittel
MXPA04000953A (es) Derivados sustituidos del acido 5,6,6a,11b-tetrahidro-7-oxa-aza-benzo[c]fluoren-6-carboxilico como antagonista de nmda.